303 related articles for article (PubMed ID: 18559513)
1. Identification of tumor-initiating cells in a p53-null mouse model of breast cancer.
Zhang M; Behbod F; Atkinson RL; Landis MD; Kittrell F; Edwards D; Medina D; Tsimelzon A; Hilsenbeck S; Green JE; Michalowska AM; Rosen JM
Cancer Res; 2008 Jun; 68(12):4674-82. PubMed ID: 18559513
[TBL] [Abstract][Full Text] [Related]
2. Notch-1 signaling promotes the cyclinD1-dependent generation of mammary tumor-initiating cells that can revert to bi-potential progenitors from which they arise.
Ling H; Jolicoeur P
Oncogene; 2013 Jul; 32(29):3410-9. PubMed ID: 22907433
[TBL] [Abstract][Full Text] [Related]
3. Identification of modulated genes by three classes of chemopreventive agents at preneoplastic stages in a p53-null mouse mammary tumor model.
Abba MC; Hu Y; Levy CC; Gaddis S; Kittrell FS; Hill J; Bissonnette RP; Brown PH; Medina D; Aldaz CM
Cancer Prev Res (Phila); 2009 Feb; 2(2):175-84. PubMed ID: 19174580
[TBL] [Abstract][Full Text] [Related]
4. Dietary suppression of the mammary CD29(hi)CD24(+) epithelial subpopulation and its cytokine/chemokine transcriptional signatures modifies mammary tumor risk in MMTV-Wnt1 transgenic mice.
Rahal OM; Machado HL; Montales MT; Pabona JM; Heard ME; Nagarajan S; Simmen RC
Stem Cell Res; 2013 Nov; 11(3):1149-62. PubMed ID: 24012543
[TBL] [Abstract][Full Text] [Related]
5. Identification and characterization of cancer initiating cells from BRCA1 related mammary tumors using markers for normal mammary stem cells.
Vassilopoulos A; Wang RH; Petrovas C; Ambrozak D; Koup R; Deng CX
Int J Biol Sci; 2008 May; 4(3):133-42. PubMed ID: 18461147
[TBL] [Abstract][Full Text] [Related]
6. Phenotypic characterization of mammosphere-forming cells from the human MA-11 breast carcinoma cell line.
Rappa G; Lorico A
Exp Cell Res; 2010 May; 316(9):1576-86. PubMed ID: 20074564
[TBL] [Abstract][Full Text] [Related]
7. CD24 and CD49f expressions of E14.5 mouse mammary anlagen cells define putative distribution of earlier embryonic mammary stem cell activities.
Song J; Ding F; Li S; Li W; Li N; Xue K
Biochem Cell Biol; 2018 Oct; 96(5):539-547. PubMed ID: 29620414
[TBL] [Abstract][Full Text] [Related]
8. Evidence for a multipotent mammary progenitor with pregnancy-specific activity.
Kaanta AS; Virtanen C; Selfors LM; Brugge JS; Neel BG
Breast Cancer Res; 2013; 15(4):R65. PubMed ID: 23947835
[TBL] [Abstract][Full Text] [Related]
9. Tumor-initiating cells are not enriched in cisplatin-surviving BRCA1;p53-deficient mammary tumor cells in vivo.
Pajic M; Kersbergen A; van Diepen F; Pfauth A; Jonkers J; Borst P; Rottenberg S
Cell Cycle; 2010 Sep; 9(18):3780-91. PubMed ID: 20855963
[TBL] [Abstract][Full Text] [Related]
10. The mammary progenitor marker CD61/beta3 integrin identifies cancer stem cells in mouse models of mammary tumorigenesis.
Vaillant F; Asselin-Labat ML; Shackleton M; Forrest NC; Lindeman GJ; Visvader JE
Cancer Res; 2008 Oct; 68(19):7711-7. PubMed ID: 18829523
[TBL] [Abstract][Full Text] [Related]
11. Cancer stem-like cells enriched with CD29 and CD44 markers exhibit molecular characteristics with epithelial-mesenchymal transition in squamous cell carcinoma.
Geng S; Guo Y; Wang Q; Li L; Wang J
Arch Dermatol Res; 2013 Jan; 305(1):35-47. PubMed ID: 22740085
[TBL] [Abstract][Full Text] [Related]
12. Ink4a/Arf(-/-) and HRAS(G12V) transform mouse mammary cells into triple-negative breast cancer containing tumorigenic CD49f(-) quiescent cells.
Kai K; Iwamoto T; Kobayashi T; Arima Y; Takamoto Y; Ohnishi N; Bartholomeusz C; Horii R; Akiyama F; Hortobagyi GN; Pusztai L; Saya H; Ueno NT
Oncogene; 2014 Jan; 33(4):440-8. PubMed ID: 23376849
[TBL] [Abstract][Full Text] [Related]
13. Isolation and molecular characterization of cancer stem cells in MMTV-Wnt-1 murine breast tumors.
Cho RW; Wang X; Diehn M; Shedden K; Chen GY; Sherlock G; Gurney A; Lewicki J; Clarke MF
Stem Cells; 2008 Feb; 26(2):364-71. PubMed ID: 17975224
[TBL] [Abstract][Full Text] [Related]
14. Wnt-responsive cancer stem cells are located close to distorted blood vessels and not in hypoxic regions in a p53-null mouse model of human breast cancer.
Vadakkan TJ; Landua JD; Bu W; Wei W; Li F; Wong ST; Dickinson ME; Rosen JM; Lewis MT; Zhang M
Stem Cells Transl Med; 2014 Jul; 3(7):857-66. PubMed ID: 24797826
[TBL] [Abstract][Full Text] [Related]
15. Separation by cell size enriches for mammary stem cell repopulation activity.
Machado HL; Kittrell FS; Edwards D; White AN; Atkinson RL; Rosen JM; Medina D; Lewis MT
Stem Cells Transl Med; 2013 Mar; 2(3):199-203. PubMed ID: 23408103
[TBL] [Abstract][Full Text] [Related]
16. FGFR2 promotes breast tumorigenicity through maintenance of breast tumor-initiating cells.
Kim S; Dubrovska A; Salamone RJ; Walker JR; Grandinetti KB; Bonamy GM; Orth AP; Elliott J; Porta DG; Garcia-Echeverria C; Reddy VA
PLoS One; 2013; 8(1):e51671. PubMed ID: 23300950
[TBL] [Abstract][Full Text] [Related]
17. CD44+ CD24(-) prostate cells are early cancer progenitor/stem cells that provide a model for patients with poor prognosis.
Hurt EM; Kawasaki BT; Klarmann GJ; Thomas SB; Farrar WL
Br J Cancer; 2008 Feb; 98(4):756-65. PubMed ID: 18268494
[TBL] [Abstract][Full Text] [Related]
18. A critical role of CD29 and CD49f in mediating metastasis for cancer-initiating cells isolated from a Brca1-associated mouse model of breast cancer.
Vassilopoulos A; Chisholm C; Lahusen T; Zheng H; Deng CX
Oncogene; 2014 Nov; 33(47):5477-82. PubMed ID: 24317509
[TBL] [Abstract][Full Text] [Related]
19. Sca-1 identifies the tumor-initiating cells in mammary tumors of BALB-neuT transgenic mice.
Grange C; Lanzardo S; Cavallo F; Camussi G; Bussolati B
Neoplasia; 2008 Dec; 10(12):1433-43. PubMed ID: 19048122
[TBL] [Abstract][Full Text] [Related]
20. Differential in vivo tumorigenicity of distinct subpopulations from a luminal-like breast cancer xenograft.
Skrbo N; Hjortland GO; Kristian A; Holm R; Nord S; Prasmickaite L; Engebraaten O; Mælandsmo GM; Sørlie T; Andersen K
PLoS One; 2014; 9(11):e113278. PubMed ID: 25419568
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
